Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02771626 |
|---|---|
| Brief Title: | Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC) |
| First Submitted : | May 6, 2016 |
| First Submitted that Met QC Criteria : | May 12, 2016 |
| First Posted : | May 13, 2016 (Estimate) |
| Results First Submitted : | January 23, 2023 |
| Results First Submitted that Met QC Criteria : | February 21, 2023 |
| Results First Posted : | March 17, 2023 |
| Certification/Extension First Submitted : | January 29, 2021 |
| Certification/Extension First Submitted that Met QC Criteria : | January 29, 2021 |
| Certification/Extension First Posted : | February 2, 2021 |
| Last Update Submitted that Met QC Criteria : | February 21, 2023 |
| Last Update Posted : | March 17, 2023 |